Dr. Joseph Kozikowski will chair a pharmaceutical industry research panel discussion on inhalation drug formulations and present at a professional education conference.
FRAMINGHAM, MA – October 2, 2002 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. will chair a pharmaceutical industry research panel and present a state-of-the art technology review to pharmacists and clinicians at the Academy of Managed Care Pharmacy Education Conference.
As an authority on the development and commercialization of advanced medical technology, Dr. Kozikowski will share his perspectives in a presentation entitled “Inhaled Drug Formulations: Pipeline, Performance, and Cost Utility” on October 7, 2002 in Washington, D.C.
The presentation will include a review of the delivery mechanisms, dosing efficiency, absorption kinetics, and design considerations for particulate and gas-phase formulations. Approaches to validation of key technical and clinical performance specifications will be reviewed. With this basis of knowledge, the pipeline of innovative inhalation drug delivery formulations, devices, and for several leading indications will be reviewed. The unique technical and regulatory challenges faced by the innovative inhalation formulations and systems will be highlighted.
Technical and industry case studies on the success of Chron’s inhaled tobramycin for cystic fibrosis and the challenges of Pfizer’s inhaled insulin will also be presented and discussed.
About The Academy of Managed Care Pharmacy:
The Academy of Managed Care Pharmacy is a national professional society dedicated to the concept and practice of pharmaceutical care in managed health care environments.
